Delivery Order SPE2DB20D3104-SPE2DB25FV8U4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for NURTEC ODT 75 mg tablets in quantities of eight units, valued at $6,465.10. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion deadline of August 20, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets in quantities of 8 units. This is a firm fixed-price delivery order valued at $27,389.85, with an ultimate completion date of July 15, 2025. The award was made through competitive procedures with no set-aside designation. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $7,823.30. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing indefinite delivery vehicle. The order is scheduled for completion by September 29, 2025, with performance based at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $57,269.72 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is set to complete by August 13, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $5,362.99. This firm fixed price delivery order, which is due for completion by August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The award was made...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,630.69 on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of NURTEC ODT 75 mg tablets in quantities of 8 units, with a ceiling value of $9,269.04. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 29, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units) with a ceiling value of $11,767.46. This firm fixed-price delivery order, which was not set-aside, represents a competitively awarded transaction and is set to be completed by June 3, 2025. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,027.37 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for NURTEC ODT 75 MG tablets (8-count packages). This is a firm fixed-price, non-set-aside contract with a completion deadline of September 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, and this delivery order represents a routine pharmaceutical supply transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV8U4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a contract ceiling value of $12,422.06. This firm fixed-price delivery order is set to be completed by July 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies a broad range of medications and medical supplies to military and veteran healthcare systems. NURTEC ODT is a migraine treatment medication, consistent with the company's portfolio of neurological and specialty medications delivered through the DLA Medical Supply Chain to support defense health requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 7/11/25 |